France
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -3.34 B
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
2 |
USD -20.98 M
|
Dec. 31, 2023 | USD 75.53 | 2.94% |
|
France |
|
3 |
USD -15.71 M
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
4 |
USD -4.47 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
5 |
USD -2.59 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
6 |
USD -1.97 M
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
7 |
USD -1.29 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
8 |
USD -853.73 K
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
9 |
USD -677.00 K
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
10 |
USD -596.02 K
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
11 |
USD -380.79 K
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
12 |
USD -362.03 K
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
13 |
USD -292.49 K
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
14 |
USD -290.29 K
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
15 |
USD -256.07 K
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
16 |
USD -172.19 K
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
17 |
USD -97.13 K
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
The Vaccines company in France with the highest Capital Expenditure is Sanofi (Paris Stock Exchange: SAN.PA) at USD -3.34 B.
The Vaccines company in France with the lowest Capital Expenditure is Aelis Farma SA (Paris Stock Exchange: AELIS.PA) at USD -97.13 K.
The top 10 Vaccines companies in France by Capital Expenditure are Sanofi, Vetoquinol SA, Valneva SE, Eurobio Scientific SA, Innate Pharma S.A., genOway SA, MedinCell S.A., Novacyt S.A., DBV Technologies S.A. and Inventiva S.A..
The bottom 10 Vaccines companies in France by Capital Expenditure are Aelis Farma SA, Adocia SA, OSE Immunotherapeutics SA, Valbiotis SA, ABIVAX SA, Nanobiotix S.A., AB Science S.A., Inventiva S.A., DBV Technologies S.A. and Novacyt S.A..